Avantor Sees Unusually High Options Volume (NYSE:AVTR)

Avantor, Inc. (NYSE:AVTRGet Free Report) was the recipient of unusually large options trading activity on Thursday. Stock investors purchased 29,996 put options on the stock. This represents an increase of approximately 463% compared to the average volume of 5,332 put options.

Avantor Stock Up 2.2 %

Avantor stock traded up $0.49 on Thursday, hitting $22.25. 1,999,364 shares of the stock traded hands, compared to its average volume of 4,118,420. Avantor has a 1 year low of $19.59 and a 1 year high of $28.00. The firm has a market cap of $15.14 billion, a P/E ratio of 48.34, a price-to-earnings-growth ratio of 3.42 and a beta of 1.28. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. The business’s fifty day simple moving average is $21.49 and its 200 day simple moving average is $23.36.

Analysts Set New Price Targets

AVTR has been the subject of a number of recent analyst reports. Robert W. Baird lowered their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a report on Monday, October 28th. Wells Fargo & Company lowered their price objective on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. Barclays dropped their target price on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, October 25th. Royal Bank of Canada restated an “outperform” rating and set a $34.00 price target on shares of Avantor in a report on Thursday, September 26th. Finally, UBS Group dropped their price objective on Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a report on Tuesday, October 8th. Two research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $27.69.

Check Out Our Latest Report on Avantor

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Hantz Financial Services Inc. grew its holdings in Avantor by 2.1% in the third quarter. Hantz Financial Services Inc. now owns 24,900 shares of the company’s stock worth $644,000 after purchasing an additional 503 shares during the period. Intech Investment Management LLC boosted its position in shares of Avantor by 1.8% in the 2nd quarter. Intech Investment Management LLC now owns 29,068 shares of the company’s stock worth $616,000 after purchasing an additional 514 shares in the last quarter. Veracity Capital LLC grew its stake in shares of Avantor by 1.0% in the 3rd quarter. Veracity Capital LLC now owns 52,359 shares of the company’s stock worth $1,355,000 after buying an additional 543 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its position in Avantor by 99.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after buying an additional 625 shares in the last quarter. Finally, US Bancorp DE raised its stake in Avantor by 6.2% during the third quarter. US Bancorp DE now owns 12,615 shares of the company’s stock valued at $326,000 after buying an additional 734 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors.

Avantor Company Profile

(Get Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Recommended Stories

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.